Continuous glucose monitoring (CGM) technology is rapidly expanding beyond Type 1 diabetes to reach a wider demographic, including Type 2 diabetics and wellness users. How manufacturers advancing CGM ...
Fraudulent data is becoming more common by the submission. So much so that the FDA recently published a press release reminding medical device manufacturers to scrutinize Third-Party Generated Data.” ...
Health equity can provide equal opportunity for patients to achieve the best care possible. Medtech leaders from Boston Scientific, Sequel Med Tech, and ZEISS Medical Technology share how healthcare ...